Moreover, the presence of a TERT promoter mutation was evaluated, with the usually mutually exclusive presence of TERT promoter mutations and ATRX mutations described in gliomas [21] as well as cutaneous melanomas [22]. This evidence concerns the gene ATRX and central nervous system cancer.